TLR3 and hepatocellular carcinoma: Several studies demonstrated that loss of function TLR3 polymorphisms are associated with an increased risk of head and neck squamous cell carcinoma (HNSCC) [25], hepatocellular carcinoma (HCC) [26,27] and CRC [28,29].